Advertisement

Organisation › Details
Sumitomo (Group)
![]() |
Start | 1919-12-24 established |
![]() |
Industry | chemicals (excl. pharmaceuticals) |
Industry 2 | pharmaceutical | |
![]() |
Region | Tokyo |
Country | Japan | |
Street | 8-11 Harumi 1-chome, Chuo-ku, Harumi Island Triton Square Office Tower Y | |
City | 104-8610 Tokyo | |
Tel | +81-3-5166-5000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | I: 50,001 to 100,0 (2007-03-31) |
Annual sales | 19,000,000,000 (sales, annual (2008c)) | |
Record changed: 2024-08-24 |
Advertisement

More documents for Sumitomo (Group)
- [1] A2 Biotherapeutics, Inc.. (3/25/24). "Press Release: A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors". Agoura Hills, CA....
- [2] Urovant Sciences. (7/5/22). "Press Release: Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland". Basel &...
- [3] Exscientia Ltd.. (5/13/21). "Press Release: Exscientia Announces Second Molecule Created Using AI from Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial"....
- [4] Gain Therapeutics, Inc.. (9/10/20). "Press Release: Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program". Bethesda, MD....
- [5] CureVac AG. (2/26/20). "Press Release: CureVac Appoints Alan Kimura, MD, PhD as Head of the Newly Created Department “Rare Diseases”". Tübingen & Boston, MA....
- [6] Exscientia Ltd.. (1/30/20). "Press Release: Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Trial"....
- [7] Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel....
- [8] Rentschler Biopharma SE. (10/4/19). "Press Release: Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base". Laupheim & Milford, MA....
- [9] Exscientia Ltd.. (3/22/19). "Press Release: Exscientia Continues Expansion with Establishment of a Subsidiary in Japan to Target the Pharmaceutical Market Across Asia". Oxford & Osaka....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top